Armistice Capital »

Imunon shares owned by Armistice Capital

Quarter-by-quarter ownership of Imunon (IMNN) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Imunon

Tip: Access up to 7 years of quarterly data

All positions including Imunon held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Imunon by Armistice Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $258k 145k 1.78
2026-03-31 $1.0M 348k 2.94

More positions owned by Armistice Capital

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Cytokinetics Com New (CYTK)
Agios Pharmaceuticals (AGIO)
Madrigal Pharmaceuticals (MDGL)
Ptc Therapeutics I (PTCT)
Supernus Pharmaceuticals (SUPN)
Travere Therapeutics (TVTX)
Immunovant (IMVT)
Incyte Corporation (INCY)
Neurocrine Biosciences (NBIX)
UnitedHealth (UNH)
Mineralys Therapeutics (MLYS)
Freshpet (FRPT)
Dyne Therapeutics (DYN)

View all positions for Armistice Capital

Top funds holding Imunon

Armistice Capital
Vanguard Capital Management
Riverview Capital Advisers
Geode Capital Management
Virtu Financial
Vanguard Fiduciary Trust
Northern Trust
UBS Group
BlackRock
Tower Research Capital
Wells Fargo & Company
Morgan Stanley
SBI Securities
Barclays
Jpmorgan Chase & Co

View all funds holding Imunon